Hôpital Gui de Chauliac

Running trials

• Not yet recruiting

  Evaluation of the Clinical Contribution of Quantitative MRI in Neuro-imaging

  NCT07245589· Assistance Publique Hopitaux De Marseille· Source

• Recruiting

  French-German Cohort Study to Determine Factors Associated With Weight Loss in Amyotrophic Lateral Sclerosis

  NCT06147843· University Hospital, Limoges· Source

• Recruiting

  Evaluation of Acute Endovascular Treatment in Symptomatic Isolated Cervical Internal Carotid Artery Occlusion (ETICA)

  NCT05832762· University Hospital, Montpellier· Source

• Recruiting

  Montpellier PROspective Cohort in Relapsing Remitting Multiple Sclerosis Using Imaging and Serologic

  NCT05962177· University Hospital, Montpellier· Source

• Recruiting

  PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years

  NCT05387954· Phase 3· Assistance Publique - Hôpitaux de Paris· Source

• Recruiting

  Performing a Low-dose, Whole-body Angiography as the First Element of an Imaging Assessment Following Stroke / TIA

  NCT02662751· Centre Hospitalier Universitaire de Nīmes· Source

• Active, not recruiting

  A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis

  NCT03958877· Phase 3· Biogen· Source

• Recruiting

  French Registry for Monitoring Pregnancies for Multiple Sclerosis

  NCT03900221· Hospices Civils de Lyon· Source

• Recruiting

  Dat'Aids Prevention

  NCT03795376· DatAids· Source

• Recruiting

  Sentinel. Ambulatory. Oral Cavity. Oropharynx (S.A.C.O)

  NCT03545256· University Hospital, Montpellier· Source

• Recruiting

  Quality of Care in French HIV Infected Patients

  NCT02898987· DatAids· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Multiple sclerosis3 recruiting
• Stroke3 recruiting
• HIV2 recruiting
• ALS (motor neurone disease)1 recruiting
• Head and neck cancer1 recruiting
• Hepatitis C1 recruiting
• Neuromyelitis optica (NMOSD)1 recruiting

Closed trials

• Terminated

  A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease

  NCT05310071· Phase 3· Biogen· Source

• Completed

  An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects

  NCT04770220· Phase 3· Alzheon Inc.· Source

• Terminated

  A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205

  NCT04241068· Phase 3· Biogen· Source

• Completed

  Cortical Superficial Siderosis and Risk of Recurrent Intracerebral Hemorrhage in Cerebral Amyloid Angiopathy.

  NCT03464344· University Hospital, Toulouse· Source

• Completed

  Study of Predictive Factors of Progression of Motor Neurone Disease

  NCT02360891· University Hospital, Lille· Source

Trial sites

• CHRU de Montpellier, Hopital Gui de Chauliac1 trial
• Department of Neurology/ Stroke Unit, Hôpital Gui de Chauliac1 trial
• Gui de Chauliac Hospital1 trial
• Gui de Chauliac Hospital, ENT Department 80 rue Augustin Fliche1 trial
• Hôpital Gui Chauliac1 trial
• Hôpital Gui de Chauliac10 trials
• Hopital Gui de Chauliac - CHRU de Montpellier1 trial
• Hôpital Gui de Chauliac - CHRU de Montpellier - Maladies Sensorielles Génétique0 trials
• Hopital Gui de Chauliac. (Site 2303)0 trials
• Neurology Department, Hopital Gui de Chauliac1 trial
• Neurology Department, Hospital Gui de Chauliac0 trials
• Tomography: Hopital Gui de Chauliac0 trials

Conditions

Diseases this institution publishes on or runs trials for.

• Narcolepsy41 works · 0 trials